Dry powder formulation for pulmonary infections: Ciprofloxacin loaded in chitosan sub-micron particles generated by electrospray
Authors:
- 1 December 2021
- journal article
- research article
- Published by Elsevier in Carbohydrate Polymers
- Vol. 273, 118543
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Can ‘extrafine’ dry powder aerosols improve lung deposition?European Journal of Pharmaceutics and Biopharmaceutics, 2015
- Aspects of pulmonary drug delivery strategies for infections in cystic fibrosis – where do we stand?Expert Opinion on Drug Delivery, 2015
- New perspectives in nanomedicinePharmacology & Therapeutics, 2013
- Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesionEuropean Journal of Pharmaceutical Sciences, 2011
- Novel chitin and chitosan nanofibers in biomedical applicationsBiotechnology Advances, 2010
- Development of Active Antimicrobial Fiber‐Based Chitosan Polysaccharide Nanostructures using ElectrospinningEngineering in Life Sciences, 2008
- Polyionic hydrocolloids for the intestinal delivery of protein drugs: Alginate and chitosan — a reviewJournal of Controlled Release, 2006
- Microencapsulated chitosan nanoparticles for lung protein deliveryEuropean Journal of Pharmaceutical Sciences, 2005
- A simple equation for the description of solute release. III. Coupling of diffusion and relaxationInternational Journal of Pharmaceutics, 1989
- Solute and penetrant diffusion in swellable polymers. II. Verification of theoretical modelsJournal of Polymer Science Part B: Polymer Physics, 1986